In STEMI patients with multivessel disease (culprit lesion already treated), this international RCT compared complete revascularization guided by functional coronary angiography (physiology-guided, n=913) vs. conventional angiography (angiography-guided, n=910) over a median follow-up of 17.9 months.
Physiology-guided revascularization significantly reduced the composite of death, MI, cerebrovascular accident, or ischemia-driven revascularization vs. angiography-guided (8.9% vs. 13.7%; HR 0.62, 95% CI 0.47–0.83; P<0.001); the safety composite (contrast-associated AKI or major bleeding) was also lower (4.6% vs. 7.1%; HR 0.63, 95% CI 0.43–0.93; P=0.02).
Median follow-up was only 17.9 months, which may be insufficient to capture longer-term outcomes; 24% female enrollment limits generalizability to women; the open-label design may have introduced performance or assessment bias.
For STEMI patients with multivessel disease, use functional coronary angiography (physiology guidance) rather than conventional angiography alone to decide which nonculprit lesions to treat — it cuts major adverse events by ~38% and also reduces procedural safety complications.